Recent Updates
- NIST Traceable Polystyrene Particle Size StandardsWith years of experience in the pharmaceutical and life science sectors, CD Bioparticles is pleased to announce the launch of its new NIST traceable Polystyrene Particle Size Standards in a variety of surface materials for research and commercial applications, including drug delivery, calibration and validation of particle size measuring instruments, diagnostics, immunoassays and flow...0 Comments 0 Shares 932 Views 0 ReviewsPlease log in to like, share and comment!
- Liposomes for Food ApplicationsCD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, is thrilled to announce the launch of its new line of liposomes specifically designed for food applications, offering promising delivery systems to enhance the bioavailability, stability, and taste of various food ingredients. In the field of food science, liposomes have attracted much...0 Comments 0 Shares 1053 Views 0 Reviews
- High-Precision Polystyrene Counting Standard Particles for Enhanced Instrument CalibrationWith years of experience in the pharmaceutical and life science sectors, CD Bioparticles announces its comprehensive line of Polystyrene Counting Standard Particles. These NIST-traceable particles offer researchers and scientists a reliable and accurate method for calibrating and validating instruments used for particle counting in both liquid and air environments. In environmental research and...0 Comments 0 Shares 1430 Views 0 Reviews
- Aptamers for Targeted Delivery and Research ApplicationsCD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, is proud to announce the availability of a comprehensive portfolio of Aptamers for researchers developing targeted diagnostics and therapeutics. These valuable tools can be applied in a wide range of applications, including drug delivery, cell imaging, disease treatment, and microbial...0 Comments 0 Shares 1373 Views 0 Reviews
- 0 Comments 0 Shares 375 Views 0 Reviews
More Stories